Form 4 Tracker
Frank L Jaksch Jr

Director · 1 filing · Latest: Jun 24, 2026

Niagen Bioscience, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
NAGE
Frank Jaksch Jr.Dec 13, 2024
Proposed Sale
$6.1937,161$230.0K